Recently, we proposed a new possible tool for targeted delivery in NSCLC [43]: it was based on a chimeric molecule [44] composed of a GL21 aptamer – which recognizes the AXL protein on the surface of NSCLC cells– and miR-34c-3p [20]. Here, AXL is linked to non-small cell lung carcinoma.